Funding Opportunity

Funding Opportunity - page 11

Showing 121–132 of 263 funding opportunities · Page 11 of 22

The Taking Flight Award seeks to promote the careers of early-career investigators to allow them to develop an independent research focus.
The purpose of these grants is to support clinical research at non-profit institutions worldwide focused on the effect of robotic-assisted bronchoscopy in the clinical care of patients with pulmonary disease. Successful proposals will study important questions related to the impacts robotic-assisted bronchoscopy on disease diagnosis and or management or patient outcomes.
The purpose of these grants is to support clinical research at non-profit institutions worldwide focused on thefield of robotic-assisted surgery.
The purpose of these grants is to promote (1) New biomedical research into the etiology, genetic and molecular mechanisms and treatment of CHARGE syndrome, or (2) New research into clinical and medical diagnosis and treatment of CHARGE syndrome.
The purpose of the grant is to fund research that will accelerate the discovery of druggable oncogenic pathways and deliver cancer interception and cancer prevention therapeutics for RUNX1-FPD children and family members.
The aim is to develop continuous C-peptide monitoring (CCPM).
The AABB Foundation awards grants for investigator- initiated original research in all aspects of blood banking, transfusion medicine and biotherapies.
EREF has established three key research priorities. The decision comes in response to the urgent need for innovative solutions and a deeper understanding of these pressing environmental challenges.
CLIP supports pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. CRI CLIP Grants are awarded to qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.
The Clinical Innovator provides funding for clinician- scientists aiming to launch innovative phase I/II or phase II.